The largest database of trusted experimental protocols

Neomycin g418

Manufactured by Thermo Fisher Scientific
Sourced in United States

Neomycin (G418) is a broad-spectrum aminoglycoside antibiotic used as a selective agent in cell culture applications. It functions by inhibiting protein synthesis in eukaryotic cells, allowing for the selection of cells that have been successfully transfected or transduced with a resistance gene.

Automatically generated - may contain errors

25 protocols using neomycin g418

1

Stable COX-2 Overexpression in Liver Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The pcDNA3.1 expression vector containing the full-length open reading frames of human COX-2 (NM_000963.3) was constructed. The sequence of the construct was confirmed. Liver cell line was transfected with pcDNA3.1 carrying COX-2 complementary DNA or empty vectors using Lipofectamine 2000 (Invitrogen). Stably transfected cells were established under selection with neomycin (G418) (Invitrogen).
+ Open protocol
+ Expand
2

Mouse GIP Expression in HT-22 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse GIP was cloned into the pEGFP-N3-NSE vector digested with HindIII and NotI. The correct sequence was verified and amplified. HT-22 cells (1 × 105 cells/well) were plated on six-well plates and transfected with a recombinant plasmid using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA). Following transfection, the cells were selected by assessing resistance to 800 μg/mL neomycin (G418) (Invitrogen, Carlsbad, CA, USA) for 2 weeks.
+ Open protocol
+ Expand
3

Stable Transfection of B16 Melanoma Cells with MULT-1

Check if the same lab product or an alternative is used in the 5 most similar protocols
MULT-1 encoding gene was amplified with GL261 cell derived cDNAs as templates using specific primers (upper primers: GGATATCATGGAGCTGACTGCCAGTAAC; lower primers: CTCGAGTCATGGGATCCCATCAATATCG), and cloned into downstream of green fluorescence protein (GFP) coding sequence in pcDNA3 plasmid (Invitrogen). After being confirmed by sequencing, the resultant plasmid (pcDNA3-GFP-MULT-1) and GFP gene carrying plasmid (PcDNA3-GFP) were stably transfected into murine B16 melanoma cells, respectively. The transfected cells were selected by limited dilution in RPMI1640 medium (Gibco) containing neomycin (G418) and 10% FCS (Invitrogen), identified by green fluorescence under fluorescence microscope and by flow cytometry, and confirmed by flow cytomerty using anti-MULT-1 mAb followed by Alexa Fluor 647-conjugated secondary antibodies. The MULT-1 gene transfected B16 cells (B16-GFP-MULT-1) and mock-transfected B16 cells (B16-GFP) were stored in liquid nitrogen and used to inoculate mice.
+ Open protocol
+ Expand
4

Derivation and Culture of Luciferase-Expressing Osteosarcoma Cell Line

Check if the same lab product or an alternative is used in the 5 most similar protocols
The luciferase-expressing OPGR80 cell line was derived from a transgenic mouse model of conditional osteosarcoma. The cell line was kindly donated by Dr. Carl Walkley (St. Vincent’s Institute, Melbourne, VIC, Australia). In this model, osteoblast-restricted deletion of p53 and pRb generate spontaneous multifocal osteosarcoma (7 (link)). The luciferase-containing vector was kindly provided by Dr. Andrew Kung (Dana-Farber Cancer Institute, Boston, MA, USA). Luciferase and phosphotransferase sequences were fused and introduced into a pMMP retrovirus to generate pMMP-LucNeo. Cells were co-transfected with pMMP-LucNeo and Eco Pac plasmid. Viral supernatants were then applied to the OPGR80 cell line for 48 h. Luciferase-expressing cells were selected with 1 mg/mL neomycin (G418, Invitrogen, Carlsbad, CA, USA).
OPGR80 cells were cultured under standard conditions of 37°C/5% CO2 in complete medium (CM), which consisted of MEM-Alpha + GlutaMAX (Invitrogen, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum (Invitrogen, Carlsbad, CA, USA) and 1% antibiotic–antimycotic (Invitrogen, Carlsbad, CA, USA).
+ Open protocol
+ Expand
5

Characterization of Human Renal Carcinoma Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human renal carcinoma cell lines (Caki-1, Achn, 786-o, 769-p, A498) and normal human renal tubular epithelial cells HKC were obtained from the Cell Type Collection Center of the Institute of Basic Medicine, Chinese academy of medical sciences (Beijing, China). The catalogue numbers of these cell lines are listed in S1 Table. 786-o and 769-p cells were cultured in RPMI 1640 medium (Hyclone) with 10% FBS (Gibco). HKC cells were cultured in DMEM/F12 (HyClone) medium with 10% FBS, added with 100 U/ml penicillin and 100 U/ml streptomycin (Invitrogen). Caki-1 cells were cultured in HAM’S/F-12 medium with 10% FBS, Caki-1-con and Caki-1-IMP3 were grown in above medium with 5μg/ml Blasticidin (Invivogen). Achn and A498 cells were cultured in minimum essential medium (MEM; HyClone) with 10% FBS, Achn-con shRNA and Achn-IMP3shRNA cells were grown in above medium with 300 μg/ml neomycin G418 (Invitrogen). Growth media were changed every other day. Mouse anti-β-actin antibody was bought from Zhongshan (Guangzhou, China). Rabbit anti-P50, P52, P65 and IκB-α phosphorylated at S32+S36 were purchased from Bioworld (Nanjing, China). NF-κB pathway inhibitor (BAY 11–7082) was bought from Sigma (Sigma-Aldrich).
+ Open protocol
+ Expand
6

Inducible Halo-tagged Linker Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
A PiggyBac vector with Neomycin resistance gene and an inducible iMC-linker Halo sequence (JHL9-pPB-tetON-lynlinker-Halo-CH(utr)_optm) was co-nucleofected with a PiggyBac transposase plasmid at volume proportions of 1:2. Nucleofection was performed using Lonza nucleofector kit V (VVCA- 1003) and the Lonza-AmaxaII device with program A-32 following manufacturer instructions. 72 h after nucleofection, successfully nucleofected PDO were selected with 400 μg ml−1 neomycin (G418, Invitrogen). Vector expression was induced 16 h before experiments by adding 1 μg ml−1 Doxycycline. iMC-linker was labeled using HaloTag Oregon Green Ligand (Promega). Labeled cells expressing the linker were selected and sorted FACS Aria flow cytometer (BD Bioscience).
+ Open protocol
+ Expand
7

Retroviral Vector Transduction in HEK293T

Check if the same lab product or an alternative is used in the 5 most similar protocols
Each retroviral vector and the pLC 10A1 retroviral packaging vector (Imgenex, San Diego, CA, USA) was co-transfected into HEK293T cells using the Lipofectamine LTX reagent (Invitrogen). After 24 h, the conditioned medium was collected as a viral solution. The retroviral vectors were infected into the cells in the medium that contained 10 μg/mL polybrene (Sigma, St. Louis, MO, USA) and allowed to incubate for 24 h. Then, the viable cells were selected using 800 μg/mL neomycin (G418; Invitrogen). The selected pooled clones were used in the biological analyses. The transfection efficiency was determined using qPCR analysis.
+ Open protocol
+ Expand
8

Stem Cell Surface Antigen Identification

Check if the same lab product or an alternative is used in the 5 most similar protocols
TROMA-1, a rat monoclonal antibody against cytokeratin Endo A, a marker of primitive endoderm, and a mouse monoclonal antibody (mAb MC-480) that recognizes the stem cell-specific cell surface antigen (SSEA-1), were purchased from the Developmental Studies Hybridoma Bank (University of Iowa, IA, USA). All trans-retinoic acid (RA) was purchased from Sigma (USA) and was dissolved in ethanol (100 mM stock). Puromycin was purchased from Sigma (USA). The plasmid vector pCDNA3, Neomycin (G418) were purchased from Invitrogen (USA). Plasmid harboring non-targeting short hairpin RNA (shRNA), pLKO.1 control vector was purchased from Open Biosystems, USA.
+ Open protocol
+ Expand
9

Preadipocyte Differentiation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
3T3-L1 preadipocytes (2 × 106 cells) were nucleofected with each construct (0.1, 0.5, 1, and 2 ug DNA) using the Amaxa Cell Line Nucleofector Kit V (Lonza #VCA-1003). Each nucleofection was seeded into a 6 well microtiter plate in calf serum medium and expanded for 6 days with700 ug of neomycin G418 (Invitrogen #10131035). Cells were transferred to 50 mm petri plates and grown. Two days after reaching confluence, cells were induced to differentiate for two days with DMEM media containing 10 % fetal bovine serum (FBS) (Life Technologies, #10437028), 0.5 μM 3-isobutyl-1-methylxanthine (IBMX, Sigma #I5879), 1 μM dexamethasone (Sigma #D4902) and 167 nM insulin (Sigma #I-6634). Cells were maintained for the next two days in DMEM medium containing 10 % FBS and 167 nM insulin. Cells were cultured for an additional 4 days in 10 % FBS/DMEM medium, during which time they differentiated into MAs filled with lipid-droplets. MAs were maintained in 10 % FBS/DMEM medium and analyzed daily for green or red fluorescent protein expression by fluorescence microscopy (FM) on Nikon (Eclipse TE2000-S) inverted microscope.
+ Open protocol
+ Expand
10

Ectopic Expression of LACTB2-NCOA2 Fusion

Check if the same lab product or an alternative is used in the 5 most similar protocols
The expression vectors were constructed by inserting the putative open reading frames (ORF) encoded by the LACTB2-NCOA2 fusion RNA and the full-length ORF of human NCOA2 into the pcDNA3.1-V5-His-TOPO expression vector (Invitrogen). The sequences of the constructs were confirmed by Sanger sequencing. Knockdown of NCOA2 was mediated by custom-made siRNA (GenePharma, Shanghai, China). Transfection of vector and siRNA was performed using Lipofectamine 2000 (Invitrogen) following manufacturer's instructions. Stably transfected cells were established under selection with neomycin (G418) (Invitrogen). Ectopic expression of target genes was confirmed by RT–PCR and/or Western blot. RNA and proteins were harvested at 48 h after transfection.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!